clinicalprojects international GmbH Joins the OmniComm CRO Preferred Program(TM) and Chooses TrialMaster(TM) for Electronic Data Capture (EDC)

International Contract Research Organization (CRO) Selects TrialMaster(R) for EDC

FT. LAUDERDALE, Fla., April 23 /PRNewswire-FirstCall/ -- OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that clinicalprojects international GmbH (CPI), a full service, global contract research organization based in Rheinbach, Germany, has become a member of OmniComm’s CRO Preferred Program. The partnership allows CPI to offer their clients the flexible, intuitive and robust EDC solution, TrialMaster, for clinical trials. The CRO program’s distinct advantages include fixed pricing with no hidden fees, complete sales and marketing support from OmniComm, a dedicated, hosted environment, and comprehensive training and support for TrialMaster.

"At CPI we have had the opportunity to become familiar with many of the EDC systems available today. We have chosen to work with the OmniComm team because of their dedication to providing the best in industry customer service and for their superior EDC product TrialMaster," said Joerg W. Breitkopf, Managing Director of CPI. "We are strong believers in cooperation and teamwork. With the assistance of our alliances' network and international partnerships, we are able to broaden our services and our global presence and offer superior products and services to our customers."

The CPI team is made up of highly-experienced, customer-oriented and professional members. Profound knowledge of ICH GCP, compliancy with the regulatory guidelines, and excessive dedication to the project, characterize CPI. CPI has an in-depth experience of EDC processes due to extensive expertise of several core members of the team with various electronic platforms. The CRO’s dedication to the sponsor, serving as partner and consultant, combined with the robust EDC technology, will bring about new advantages to existing and prospective customers of CPI.

"Our CRO Preferred program continues to expand internationally and the significant industry experience of our team in Bonn, Germany has allowed us to deliver the high quality customer service that our customers require. OmniComm’s international headquarters, is looking forward to working with the team at CPI," said Stephen Johnson, COO of OmniComm. "Our CRO program offers members substantial benefits such as the fixed pricing and complete marketing support that other vendors simply cannot compete with. Partnering with OmniComm allows CROs to offer their customers a first class EDC product with predictable pricing that gives them a competitive edge."

About clinicalprojects international GmbH
CPI (www.clinicalprojects.de) is an independent contract research organization (CRO) located near Bonn, Germany. CPI’s team provides diligent, superior quality, proactive clinical services that enable the pharmaceutical, biotech and medical devices industries to enhance development, reduce costs, and bring new therapies to the global market. As a full-service CRO, we offer all or any single service from planning of study design and protocol writing to approval processes, GCP-compliant study conduct and monitoring to final report and publication. CPI’s team is supporting international trials both in Europe and the US.

About OmniComm
OmniComm Systems, Inc. (www.OmniComm.com) provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. OmniComm’s growing base of satisfied customers is a direct result of the company’s commitment to deliver products and services that ensure ease of use, faster study build, ease of integration and better performance. OmniComm’s client intuitive pricing model allows companies that range from small to mid-size to large scale institutions to safely and efficiently capitalize on their clinical research investments. OmniComm Systems, Inc. has corporate headquarters in Ft. Lauderdale, Florida with offices in Bonn, Germany, Tula, Russia, Illinois, California, Maryland, New York, North Carolina and Texas.

Safe Harbor Disclaimer
Statements about OmniComm’s future expectations, including without limitation, future revenues and earnings, plans and objectives for the future operations, future agreements, future economic performance, operations and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. OmniComm intends that such forward-looking statements be subject to the Safe Harbors created thereby. Since these statements involve risks and uncertainties, including but not limited to economic competitive, governmental, contractual and technological factors affecting OmniComm’s operations, markets and profitability, actual results could differ materially and adversely from the expected results.

CONTACT: Steve Johnson, OmniComm Systems, Inc., +1-954-473-1254 sjohnson@omnicomm.com

Back